HONG KONG, Feb. 4, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the"Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, announces that Golden Meditech Technology (Shanghai) Company Limited*, a wholly-owned
Ying Peng Hui Kang Fund is a limited partnership established in the People's Republic of China ("PRC") with its sole investment being 78,874,106 ordinary shares of China Cord Blood Corporation ("CCBC"), representing 65.4% of the entire issued share capital of CCBC.
Such investment in Ying Peng Hui Kang Fund may yield potential annual rate of return of 9%, and may bring additional potential return to the Company, as a limited partner, when Ying Peng Hui Kang Fund disposes of its equity interest in CCBC.
On the same date, the Company, Nanjing Ying Peng Asset Management Co., Ltd.* ("Ying Peng Asset Management"), Shanghai Guotai Junan Haojing Investment Management Limited* ("Guotai Junan") and Hengqin Investment entered into a general partner framework agreement pursuant to which, subject to the Company and Guotai Junan entering into a legally-binding agreement, the Company intends to become one of the general partners and fund managers of Ying Peng Hui Kang Fund with the rights, powers, benefits and obligations equivalent to those of Guotai Junan in the Ying Peng Hui Kang Fund (the "Potential GP Arrangement"). The Company will make further announcement in due course on the Potential GP Arrangement.
The Company intends to utilise part of the proceeds from the sale of equity interest in CCBC which was completed on 31 January 2018 to fund the Acquisition.
As the transaction constitutes a very substantial acquisition under the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited (the "Hong Kong Listing Rules"), the Company will hold an extraordinary general meeting for shareholders to approve the transaction.
Details have been published by the Company in accordance with the Hong Kong Listing Rules and posted on the Company's website as follows: http://www.goldenmeditech.com/eng/ir/announcements.php?year=2018
About Golden Meditech Holdings Limited (SEHK stock code: 00801)
Golden Meditech (www.goldenmeditech.com) is a leading integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant positions in several markets including the medical devices market and the hospital management market in the healthcare industry, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, Golden Meditech will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.
About Hengqin Long Xi II Investment Center (Limited Partnership)*
Hengqin Investment is a limited partnership established in the PRC. It is a special purpose fund established to invest in Ying Peng Hui Kang Fund. Hengqin Investment is a middle class limited partner of Ying Peng Hui Kang Fund.
About Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership)*
Ying Peng Hui Kang Fund is a merger and acquisition fund focusing on the medical and healthcare industry. It is founded by Nanjing Xinjiekou Department Store Co., Ltd. and several other institutions. Its fund managers are Ying Peng Asset Management and Guotai Junan.
About Nanjing Ying Peng Asset Management Co., Ltd.*
Ying Peng Asset Management is a company established in the PRC with limited liability and is principally engaged in the business of asset management, investment management, equity investment and venture capital investment.
About Shanghai Guotai Junan Haojing Investment Management Limited*
Guotai Junan is a company established in the PRC with limited liability and is principally engaged in the business of private equity investment and management.
* For identification purpose only.
View original content:http://www.prnewswire.com/news-releases/golden-meditech-acquires-1614-interest-of-ying-peng-hui-kang-fund-300593091.html
SOURCE Golden Meditech Holdings Limited
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All